Exploring Sjögren’s syndrome through interdisciplinary perspectives: a concise review

References

• Vivino, F. B. Sjogren’s Syndrome: Clinical Aspects. Clin. Immunol. 2017, 182, 48–54. DOI: 10.1016/j.clim.2017.04.005.
   PubMed Web of Science ®Google Scholar
• Nordmark, G.; Alm, G. V.; Rönnblom, L. Mechanisms of Disease: Primary Sjögren’s Syndrome and the Type I Interferon System. Nat. Clin. Pract. Rheumatol. 2006, 2(5), 262–269. DOI: 10.1038/ncprheum0173.
   PubMedGoogle Scholar
• Seeliger, T.; Kramer, E.; Konen, F. F.; Zehrfeld, N.; Beider, S.; Prenzler, N. K.; Gödecke, V.; Witte, T.; Skripuletz, T.; Ernst, D., et al. Sjögren’s Syndrome with and without Neurological Involvement. J. Neurol. 2023, 270(6), 2987–2996.
   PubMed Web of Science ®Google Scholar
• Brito-Zerón, P.; Theander, E.; Baldini, C.; Seror, R.; Retamozo, S.; Quartuccio, L.; Bootsma, H.; Bowman, S. J.; Dörner, T.; Gottenberg, J.-E., et al. Early Diagnosis of Primary Sjögren’s Syndrome: EULAR-SS Task Force Clinical Recommendations. Expert Rev. Clin. Immunol. 2016, 12(2), 137–156.
   PubMed Web of Science ®Google Scholar
• Greenan, E.; Tynan, G.; Collins, D.; Murphy, C. C.; Flood, M.; Ní Gabhann‐Dromgoole, J. Beyond Dry Eye: The Greater Extent of Sjögren’s Systemic Disease Symptoms, the Impact of COVID-19 and Perceptions Towards Telemedicine Identified Through a Patient Co-Designed Study. Health Expect. July 2023, 6, 2252–2263. DOI: 10.1111/hex.13823.
   PubMed Web of Science ®Google Scholar
• Wei, W.; Ahmad, S. S.; Chi, S.; Xie, Y.; Kamal, M. A.; Li, J. From Molecular Mechanism to the Etiology of Sjogren Syndrome. Curr. Pharm. Des. 2019, 24(35), 4177–4185. DOI: 10.2174/1381612824666181016154033.
   Web of Science ®Google Scholar
• Wu, K. Y.; Kulbay, M.; Tanasescu, C.; Jiao, B.; Nguyen, B. H.; Tran, S. D. An Overview of the Dry Eye Disease in Sjögren’s Syndrome Using Our Current Molecular Understanding. Int. J. Mol. Sci. 2023, 24(2), 1580. DOI: 10.3390/ijms24021580.
   PubMed Web of Science ®Google Scholar
• Yao, Y.; Liu, Z.; Jallal, B.; Shen, N.; Rönnblom, L. Type I Interferons in Sjögren’s Syndrome. Autoimmun. Rev. 2013, 12(5), 558–566. DOI: 10.1016/j.autrev.2012.10.006.
   PubMed Web of Science ®Google Scholar
• Sjögren’s Foundation. World Sjögren’s Day Is on July 23. Sjögren’s Foundation. https://sjogrens.org/news/2022/world-sjogrens-day-is-on-july-23 (accessed June 6, 2022).
   Google Scholar
• PC, F. O. X. Autoimmune Diseases and Sjögren’s Syndrome. Ann. NY Acad. Sci. 2007, 1098(1), 15–21. DOI: 10.1196/annals.1384.003.
   PubMedGoogle Scholar
• Lee, Y. T.; Wu, C. Y.; Chou, I. J.; Liu, C. H. Sjogren’s Syndrome Related Autoimmune Encephalopathy Presenting as Depression and Involuntary Agitation in a 15-Year-Old Girl: A Case Report. Front. Immunol. 2023, 14, 14. DOI: 10.3389/fimmu.2023.1145948.
   Web of Science ®Google Scholar
• Basiaga, M. L.; Stern, S. M.; Mehta, J. J.; Edens, C.; Randell, R. L.; Pomorska, A.; Irga-Jaworska, N.; Ibarra, M. F.; Bracaglia, C.; Nicolai, R., et al. Childhood Sjögren Syndrome: Features of an International Cohort and Application of the 2016 ACR/EULAR Classification Criteria. Rheumatol. (Oxford). 2021, 60(7), 3144–3155.
   PubMed Web of Science ®Google Scholar
• Al-Hashimi, I. Sjögren’s Syndrome: Diagnosis and Management. Women’s Health. 2007, 3(1), 107–122. DOI: 10.2217/17455057.3.1.107.
   PubMedGoogle Scholar
• Maslinska, M.; Kostyra-Grabczak, K. The Role of Virus Infections in Sjögren’s Syndrome. Front. Immunol. 2022, 13. DOI: 10.3389/fimmu.2022.823659.
   Google Scholar
• Alfaris, N.; Curiel, R.; Tabbara, S.; Irwig, M. S. Autoimmune Thyroid Disease and Sjögren Syndrome. J. Clin. Rheumatol. 2010, 16(3), 146–147. DOI: 10.1097/RHU.0b013e3181d52a28.
   PubMed Web of Science ®Google Scholar
• Arango, M. T.; Shoenfeld, Y.; Cervera, R.; Anaya, J. M. Infection and Autoimmune Diseases. In Autoimmunity: From Bench to Bedside, Anaya, J., Shoenfeld, Y., Rojas-Villarraga, A., Levy, R. Cervera, R., Eds. El Rosario University Press: Bogota (Colombia), 2013; https://www.ncbi.nlm.nih.gov/books/NBK459437/
   Google Scholar
• Christodoulou, M. I.; Kapsogeorgou, E. K.; Moutsopoulos, H. M. Characteristics of the Minor Salivary Gland Infiltrates in Sjögren’s Syndrome. J. Autoimmun. 2010, 34(4), 400–407. DOI: 10.1016/j.jaut.2009.10.004.
   PubMed Web of Science ®Google Scholar
• Baranek, T.; Zucchini, N.; Dalod, M. Plasmacytoid Dendritic Cells and the Control of Herpesvirus Infections. Viruses. 2009, 1(3), 383–419. DOI: 10.3390/v1030383.
   PubMed Web of Science ®Google Scholar
• Dörner, T.; Lipsky, P. E. Abnormalities of B Cell Phenotype, Immunoglobulin Gene Expression and the Emergence of Autoimmunity in Sjögren’s Syndrome. Arthritis Res. 2002, 4(6), 360. DOI: 10.1186/ar603.
   PubMedGoogle Scholar
• Varin, M. M.; Guerrier, T.; Devauchelle-Pensec, V.; Jamin, C.; Youinou, P.; Pers, J. O. In Sjögren’s Syndrome, B Lymphocytes Induce Epithelial Cells of Salivary Glands into Apoptosis Through Protein Kinase C Delta Activation. Autoimmun. Rev. 2012, 11(4), 252–258. DOI: 10.1016/j.autrev.2011.10.005.
   PubMed Web of Science ®Google Scholar
• Dalle Vedove, E.; Costabile, G.; Merkel, O. M. Mannose and Mannose‐6‐Phosphate Receptor–Targeted Drug Delivery Systems and Their Application in Cancer Therapy. Adv. Healthc. Mater. 2018, 7(14). DOI: 10.1002/adhm.201701398.
   PubMed Web of Science ®Google Scholar
• Fakher, H. E.; El Gazzar, N. M.; Mabrouk, M. M.; Nada, D. W. The Study of Serum Muscarinic Acetylcholine Receptor Subtype 3 (M3achR)-Specific Autoantibodies Level in Rheumatoid Arthritis Patients with Secondary Sjogren Syndrome. BMC Rheumatol. 2023, 7(1), 45. DOI: 10.1186/s41927-023-00368-1.
   PubMedGoogle Scholar
• Iaccarino, L.;, Ghirardello, A.; Canova, M.; Zen, M.; Bettio, S.; Nalotto, L.; Punzi, L.; Doria, A. Anti-Annexins Autoantibodies: Their Role As Biomarkers of Autoimmune Diseases Autoimmun. Rev. 2011, 10(9), 553–558
   PubMed Web of Science ®Google Scholar
• Alonso-Larruga, A.; Bustabad, S.; Navarro-Gonzálvez, J. A.; Rodríguez-Lozano, B.; Franco, A.; Barrios, Y. Isolated Ro52 Antibodies As Immunological Marker of a Mild Phenotype of Undifferentiated Connective Tissue Diseases. Int. J. Rheumatol. 2017, 2017, 1–6. DOI: 10.1155/2017/3076017
   Google Scholar
• Ohlsson, M.; Jonsson, R.; Brokstad, K. A. Subcellular Redistribution and Surface Exposure of the Ro52, Ro60 and La48 Autoantigens During Apoptosis in Human Ductal Epithelial Cells: A Possible Mechanism in the Pathogenesis of Sjögren’s Syndrome. Scand J. Immunol. 2002, 56(5), 456–469. DOI: 10.1046/j.1365-3083.2002.01072_79.x.
   PubMed Web of Science ®Google Scholar
• Moulton, V. R. Sex Hormones in Acquired Immunity and Autoimmune Disease. Front. Immunol. 2018, 9. DOI: 10.3389/fimmu.2018.02279.
   Web of Science ®Google Scholar
• McCoy, S. S.; Sampene, E.; Baer, A. N. Association of Sjögren’s Syndrome with Reduced Lifetime Sex Hormone Exposure: A Case–Control Study. Arthritis Care Res. (Hoboken). 2020, 72(9), 1315–1322. DOI: 10.1002/acr.24014.
   PubMed Web of Science ®Google Scholar
• Xuan, Y.; Zhang, X.; Wu, H. Impact of Sex Differences on the Clinical Presentation, Pathogenesis, Treatment and Prognosis of Sjögren’s Syndrome. Immunology. 2024, 171(4), 513–524. Epub 2023 Dec 29. PMID: 38156505. DOI: 10.1111/imm.13740.
   PubMed Web of Science ®Google Scholar
• Simmonds, M.; Gough, S. The HLA Region and Autoimmune Disease: Associations and Mechanisms of Action. Curr. Genomics. 2007, 8(7), 453–465. DOI: 10.2174/138920207783591690.
   PubMed Web of Science ®Google Scholar
• Bjordal, O.; Norheim, K. B.; Rødahl, E.; Jonsson, R.; Omdal, R. Primary Sjögren’s Syndrome and the Eye. Surv. Ophthalmol. 2020, 65(2), 119–132. DOI: 10.1016/j.survophthal.2019.10.004.
   PubMed Web of Science ®Google Scholar
• Fye, K. H.; Terasaki, P. I.; Michalski, J. P.; Daniels, T. E.; Opelz, G.; Talal, N. Relationship of Hla-Dw3 and Hla-B8 to Sjögren’S Syndrome. Arthritis Rheum. 1978, 21(3), 337–342. DOI: 10.1002/art.1780210308.
   PubMedGoogle Scholar
• Cruz-Tapias, P.; Rojas-Villarraga, A.; Maier-Moore, S.; Anaya, J. M. HLA and Sjögren’s Syndrome Susceptibility. A Meta-Analysis of Worldwide Studies. Autoimmun. Rev. 2012, 11(4), 281–287. DOI: 10.1016/j.autrev.2011.10.002.
   PubMed Web of Science ®Google Scholar
• Fugl, A.; Andersen, C. L. Epstein-Barr Virus and Its Association with Disease - a Review of Relevance to General Practice. BMC Fam. Pract. 2019, 20(1), 62. DOI: 10.1186/s12875-019-0954-3.
   PubMedGoogle Scholar
• Khatri, B.; Tessneer, K. L.; Rasmussen, A.; Aghakhanian, F.; Reksten, T. R.; Adler, A.; Alevizos, I.; Anaya, J.-M.; Aqrawi, L. A.; Baecklund, E., et al. Genome-Wide Association Study Identifies Sjögren’s Risk Loci with Functional Implications in Immune and Glandular Cells. Nat. Commun. 2022, 13(1), 4287.
   PubMed Web of Science ®Google Scholar
• Fox, R. I. Extraglandular Manifestations of Sjögren’s Syndrome (SS): Dermatologic, Arthritic, Endocrine, Pulmonary, Cardiovascular, Gastroenterology, Renal, Urology, and Gynecologic Manifestations. In Sjögren’s Syndrome; Springer: New York, NY, 2011; pp. 285–316.
   Google Scholar
• Lee, C. T.; Strek, M. E. The Other Connective Tissue Disease-Associated Interstitial Lung Diseases: Sjogren’s Syndrome, Mixed Connective Tissue Disease, and Systemic Lupus Erythematosus. Curr. Opin. Pulm. Med. 2021, 27(5), 388–395. DOI: 10.1097/MCP.0000000000000791.
   PubMed Web of Science ®Google Scholar
• Flament, T.; Bigot, A.; Chaigne, B.; Henique, H.; Diot, E.; Marchand-Adam, S. Pulmonary Manifestations of Sjögren’s Syndrome. Eur. Respir. Review. 2016, 25(140), 110–123. DOI: 10.1183/16000617.0011-2016.
   PubMed Web of Science ®Google Scholar
• İşik, R.; Ege, F. Musculoskeletal Manifestations in Sjogren’s Syndrome; London, UK: IntechOpen, 2023.
   Google Scholar
• Tobón, G. J.; Pers, J. O.; Devauchelle-Pensec, V.; Youinou, P. Neurological Disorders in Primary Sjögren’s Syndrome. Autoimmune Dis. 2012, 2012, 645967. DOI: 10.1155/2012/645967.
   PubMedGoogle Scholar
• Scofield, R. H. Vasculitis in Sjögren’s Syndrome. Curr. Rheumatol. Rep. 2011, 13(6), 482–488. DOI: 10.1007/s11926-011-0207-5.
   PubMed Web of Science ®Google Scholar
• Maripuri, S.; Grande, J. P.; Osborn, T. G.; Fervenza, F. C.; Matteson, E. L.; Donadio, J. V.; Hogan, M. C. Renal Involvement in Primary Sjögren’s Syndrome: A Clinicopathologic Study. Clin. J. Am. Soc. Nephrol. 2009, 4(9), 1423–1431. 10.2215/CJN.00980209.
   PubMed Web of Science ®Google Scholar
• Negrini, S.; Emmi, G.; Greco, M., Borro, M.; Sardanelli, F.; Murdaca, G.; Indiveri, F.; Puppo, F. Sjögren’s Syndrome: A Systemic Autoimmune Disease. Clin. Exp. Med. 2022, 22(1), 9–25.
   PubMed Web of Science ®Google Scholar
• Meena, D. S.; Bohra, G. K. Primary Sjogren’s Syndrome Presenting As Autoimmune Cytopenia. Clin. Pract. 2019, 9(4), 1190. DOI: 10.4081/cp.2019.1190.
   PubMed Web of Science ®Google Scholar
• Mavragani, C. P.; Moutsopoulos, H. M. The Geoepidemiology of Sjögren’s Syndrome. Autoimmun. Rev. 2010, 9(5), A305–A310. DOI: 10.1016/j.autrev.2009.11.004.
   PubMed Web of Science ®Google Scholar
• Martorell-Marugán, J.; Chierici, M.; Jurman, G.; Alarcón-Riquelme, M. E.; Carmona-Sáez, P. Differential Diagnosis of Systemic Lupus Erythematosus and Sjögren’s Syndrome Using Machine Learning and Multi-Omics Data. Comput. Biol. Med. 2023, 152, 106373. DOI: 10.1016/j.compbiomed.2022.106373.
   PubMed Web of Science ®Google Scholar
• Gofinet Pasoto, S.; Adriano de Oliveira Martins, V.; Bonfa, E. Sjogren’s Syndrome and Systemic Lupus Erythematosus: Links and Risks. Open Access Rheumatol. 2019, 11, 33–45. DOI: 10.2147/OARRR.S167783.
   PubMedGoogle Scholar
• Dinescu, S. C.; Ciurea, P. L.; Vreju, F. A.; Săndulescu, D. L.; Musetescu, A. E. Hepatitis C Virus Induced Sjogren Syndrome - Clinical and Imaging Features. Curr. Health Sci. J. 2017, 43(1), 78–82. DOI: 10.12865/CHSJ.43.01.12.
   PubMedGoogle Scholar
• Alhazmi, A. A.; Almuflihi, A.; Aly, M. M.; Mohammed, A.; Alshehri, A. Hepatitis C-Induced Sjögren’s Syndrome with Positive Serology: A Case Report. Cureus. 2021, 13(12), e20091. DOI: 10.7759/cureus.20091.
   PubMed Web of Science ®Google Scholar
• Vílchez-Oya, F.; Balastegui Martin, H.; García-Martínez, E.; Corominas, H. Not All Autoantibodies Are Clinically Relevant. Classic and Novel Autoantibodies in Sjögren’s Syndrome: A Critical Review. Front. Immunol. 2022, 13. DOI: 10.3389/fimmu.2022.1003054.
   PubMed Web of Science ®Google Scholar
• Fayyaz, A.; Kurien, B. T.; Scofield, R. H. Autoantibodies in Sjögren’s Syndrome. Rheum. Dis. Clin. North Am. 2016, 42(3), 419–434. DOI: 10.1016/j.rdc.2016.03.002.
   PubMed Web of Science ®Google Scholar
• Chen, K. S.; Jiang, M. C.; Li, C. J.; Liu, O. K.; Tsai, C. S. Discrimination Between Sjögren’s and Non-Sjögren’s Sicca Syndrome by Sialoscintigraphy and Antibodies Against α-Fodrin and Ro/La Autoantigens. J. Int. Med. Res. 2009, 37(4), 1088–1096. DOI: 10.1177/147323000903700413.
   PubMed Web of Science ®Google Scholar
• Verstappen, G. M.; Pringle, S.; Bootsma, H.; Kroese, F. G. M. Epithelial–Immune Cell Interplay in Primary Sjögren Syndrome Salivary Gland Pathogenesis. Nat. Rev. Rheumatol. 2021, 17(6), 333–348. DOI: 10.1038/s41584-021-00605-2.
   PubMed Web of Science ®Google Scholar
• Liao, R.; Yang, H. T.; Li, H., Liu, L. X.; Li, K.; Li, J. J.; Liang, J.; Hong, X. P.; Chen, Y. L.; Liu, D. Z. Recent Advances of Salivary Gland Biopsy in Sjögren’s Syndrome. Front. Med. (Lausanne). 2022, 8. DOI: 10.3389/fmed.2021.792593.
   Web of Science ®Google Scholar
• Fisher, B. A.; Jonsson, R.; Daniels, T.; Bombardieri, M.; Brown, R. M.; Morgan, P.; Bombardieri, S.; Ng, W.-F.; Tzioufas, A. G.; Vitali, C., et al. Standardisation of Labial Salivary Gland Histopathology in Clinical Trials in Primary Sjögren’s Syndrome. Ann. Rheum. Dis. 2017, 76(7), 1161–1168.
   PubMed Web of Science ®Google Scholar
• Spijkervet, F. K.; Haacke, E.; Kroese, F. G.; Bootsma, H.; Vissink, A. Parotid Gland Biopsy, the Alternative Way to Diagnose Sjögren Syndrome. Rheum. Dis. Clin. North Am. 2016, 42(3), 485–499. DOI: 10.1016/j.rdc.2016.03.007
   PubMed Web of Science ®Google Scholar
• Beckman, K.; Luchs, J.; Milner, M. Making the Diagnosis of Sjogren’s Syndrome in Patients with Dry Eye. Clin. Ophthalmol. December 2015, 43. DOI: 10.2147/OPTH.S80043.
   PubMedGoogle Scholar
• Rasmussen, A.; Stone, D. U.; Kaufman, C. E.; Hefner, K. S.; Fram, N. R.; Siatkowski, R. L.; Huang, A. J. W.; Chodosh, J.; Rasmussen, P. T.; Fife, D. A., et al. Reproducibility of Ocular Surface Staining in the Assessment of Sjögren Syndrome–Related Keratoconjunctivitis Sicca: Implications on Disease Classification. ACR Open Rheumatol. 2019, 1(5), 292–302.
   PubMedGoogle Scholar
• Del Rosario Sánchez Valerio, M. Eye Diseases - Recent Advances, New Perspectives and Therapeutic Options; London, UK: IntechOpen, 2023
   Google Scholar
• Versura, P.; Profazio, V.; Campos, E. C. Performance of Tear Osmolarity Compared to Previous Diagnostic Tests for Dry Eye Diseases. Curr. Eye Res. 2010, 35(7), 553–564. DOI: 10.3109/02713683.2010.484557.
   PubMed Web of Science ®Google Scholar
• Wise, R. J.; Sobel, R. K.; Allen, R. C. Meibography: A Review of Techniques and Technologies. Saudi J. Ophthalmol. 2012, 26(4), 349–356. DOI: 10.1016/j.sjopt.2012.08.007.
   PubMedGoogle Scholar
• Shimazaki, J.; Goto, E.; Ono, M.; Shimmura, S.; Tsubota, K. Meibomian Gland Dysfunction in Patients with Sjögren Syndrome. Ophthalmology. 1998, 105(8), 1485–1488. DOI: 10.1016/S0161-6420(98)98033-2.
   PubMed Web of Science ®Google Scholar
• Arita, R. Meibography: A Japanese Perspective. Invest. Ophthalmol. Visual Sci. 2018, Nov 1, 59(14), DES48–55. DOI: 10.1167/iovs.17-23631.
   PubMed Web of Science ®Google Scholar
• Xu, S.; Zhu, C.; Jiang, J.; Cheng, H.; Wang, P.; Hong, J.; Yang, S.; Li, Z.; Wang, X. Non-Invasive Diagnosis of Primary Sjögren’s Syndrome Using Ultrasonography and Transcriptome Biomarkers. Clinical Immunology. 2023, 255, 109739. DOI: 10.1016/j.clim.2023.109739.
   PubMed Web of Science ®Google Scholar
• Nilsson, A.; Tufvesson, E.; Hesselstrand, R.; Olsson, P.; Wollmer, P.; Mandl, T. Increased B-Cell Activating Factor, Interleukin-6, and Interleukin-8 in Induced Sputum from Primary Sjögren’s Syndrome Patients. Scand. J. Rheumatol. 2019, 48(2), 149–156. DOI: 10.1080/03009742.2018.1473488.
   PubMed Web of Science ®Google Scholar
• Luzu, J.; Labbé, A.; Réaux-Le Goazigo, A.; Rabut, G.; Liang, H.; Dupas, B.; Blautain, B.; Sène, D.; Baudouin, C. In vivo Confocal Microscopic Study of Corneal Innervation in Sjögren’s Syndrome with or without Small Fiber Neuropathy. Ocul. Surf. 2022, 25, 155–162. DOI: 10.1016/j.jtos.2022.07.003.
   PubMed Web of Science ®Google Scholar
• Villani, E.; Baudouin, C.; Efron, N.; Hamrah, P.; Kojima, T.; Patel, S. V.; Pflugfelder, S. C.; Zhivov, A.; Dogru, M. In vivo Confocal Microscopy of the Ocular Surface: From Bench to Bedside. Curr. Eye Res. 2014, 39(3), 213–231.
   PubMed Web of Science ®Google Scholar
• Kassan, S. S.; Moutsopoulos, H. M. Clinical Manifestations and Early Diagnosis of Sjögren Syndrome. Arch. Int. Med. 2004, 164(12), 1275. DOI: 10.1001/archinte.164.12.1275.
   PubMedGoogle Scholar
• Stefanski, A. L.; Tomiak, C.; Pleyer, U.; Dietrich, T.; Burmester, G. R.; Dörner, T. The Diagnosis and Treatment of Sjögren’s Syndrome. Dtsch Arztebl Int. May 2017. DOI: 10.3238/arztebl.2017.0354.
   Google Scholar
• Geerling, G.; Tauber, J.; Baudouin, C.; Goto, E.; Matsumoto, Y.; O’Brien, T.; Rolando, M.; Tsubota, K.; Nichols, K. K. The International Workshop on Meibomian Gland Dysfunction: Report of the Subcommittee on Management and Treatment of Meibomian Gland Dysfunction. Invest. Ophthalmol. Vis. Sci. 2011, 52(4), 2050–2064.
   PubMed Web of Science ®Google Scholar
• Linardaki, G.; Moutsopoulos, H. M.; MOUTSOPOULOS, H. M. The Uncertain Role of Immunosuppressive Agents in Sjögren’s Syndrome. Cleve. Clin. J. Med. 1997, 64(10), 523–526. DOI: 10.3949/ccjm.64.10.523.
   PubMed Web of Science ®Google Scholar
• Gheorghe, D. N.; Popescu, D. M.; Dinescu, S. C.; Silaghi, M.; Surlin, P.; Ciurea, P. L. Association Between Sjögren’s Syndrome and Periodontitis: Epidemiological, Fundamental and Clinical Data: A Systematic Review. Diagnostics. 2023, 13(8), 1401. DOI: 10.3390/diagnostics13081401.
   Web of Science ®Google Scholar
• van den Hoogen, L. L.; van Laar JM; van Laar, J. M. Targeted Therapies in Systemic Sclerosis, Myositis, Antiphospholipid Syndrome, and Sjögren’s Syndrome. Best Pract. Res. Clin. Rheumatol. 2020, 34(1), 101485. DOI: 10.1016/j.berh.2020.101485.
   PubMed Web of Science ®Google Scholar
• Verstappen, G. M.; van Nimwegen JF; Vissink, A.; Kroese, F. G. M.; Bootsma, F. G.; van Nimwegen, J. F. The Value of Rituximab Treatment in Primary Sjögren’s Syndrome. Clin. Immunol. 2017, 182, 62–71. DOI: 10.1016/j.clim.2017.05.002.
   PubMed Web of Science ®Google Scholar
• van der Heijden EHM; Kruize, A. A.; Radstake, T. R. D. J.; van Roon JAG; van der Heijden, E. H. M.; van Roon, J. A. G. Optimizing Conventional DMARD Therapy for Sjögren’s Syndrome. Autoimmun. Rev. 2018, 17(5), 480–492. DOI: 10.1016/j.autrev.2018.03.003.
   PubMed Web of Science ®Google Scholar
• Miyamoto, S. T.; Lendrem, D. W.; Ng, W. F.; Hackett, K. L.; Valim, V. Managing Fatigue in Patients with Primary Sjögren’s Syndrome: Challenges and Solutions. Rheumatol. 2019, 11, 77–88. DOI: 10.2147/OARRR.S167990.
   Web of Science ®Google Scholar
• Mæland, E.; Miyamoto, S. T.; Hammenfors, D.; Valim, V.; Jonsson, M. V. Understanding Fatigue in Sjögren’s Syndrome: Outcome Measures, Biomarkers and Possible Interventions. Front. Immunol. 2021, 12, 703079. DOI: 10.3389/fimmu.2021.703079.
   PubMed Web of Science ®Google Scholar
• Chaudhary, A.; Singh, N. Contribution of World Health Organization in the Global Acceptance of Ayurveda. J. Ayurveda. Integr. Med. 2011, 2(4), 179–186. DOI: 10.4103/0975-9476.90769.
   PubMedGoogle Scholar
• Vagbhata. Ashtanga Hridaya of Vagbhata – with 2 Commentaries, Vaidya BHP; ed. Chaukhambha Orientalia: Varanasi, 2017; https://archive.org/details/Ashtanga.Hridaya.of.Vagbhata/page/n175/mode/2up
   Google Scholar
• Sumantran, V. N.; Tillu, G. Insights on Personalized Medicine from Ayurveda. J. Altern. Complementary Med. 2013, 19(4), 370–375. DOI: 10.1089/acm.2011.0698.
   PubMed Web of Science ®Google Scholar
• Dhiman, K. Shushkakshipaka (Dry Eye Syndrome): A Case Study. Int. J. Ayurveda Res. 2011, 2(1), 53. DOI: 10.4103/0974-7788.83185.
   PubMedGoogle Scholar
• Timmapur, G.; Fiaz, S. Efficacy of Triphala Ghrita and Goghrita Manda Tarpana in the Management of Shushkakshipaka W.S.r. to Dry Eye Syndrome: An Open Labelled Randomized Comparative Clinical Trial. AYU (An Int. Quarterly J. Res. Ayurveda). 2020, 41(1), 52. DOI: 10.4103/ayu.AYU_108_18.
   PubMedGoogle Scholar
• Sushruta. Sushruta E-Samhita, National Institute of Indian Medical Heritage: https://niimh.nic.in/ebooks/esushruta/
   Google Scholar
• Premcy, C. R.; Management of Shushkakshipaka W.S.r. to Dry Eye Syndrome – A Single Case Study. J. Ayurveda Integr. Med. 2022, 7, (5). https://jaims.in/jaims/article/view/1965/2240.
   Google Scholar
• Nirmal Krishnan, R.; Swarna Ranjita Bhat, S. M. P.; An Ayurvedic Approach to the Management of Shushkakshipaka W.S.r. to Dry Eye Syndrome – A Case Report. J. Ayurveda Integr. Med. 2022, 7, (8). https://jaims.in/jaims/article/view/1963/2401.
   Google Scholar
• Gowda, D. V.; Muguli, G.; Deshpande, R.; Paramesh, R.; Gowda, D.; Deshpande, R. D. Phytochemical and Pharmacological Actions of Triphala: Ayurvedic Formulation – A Review. Int. J. Pharma. Sci. Rev. Res. 2012;15, 2, 61–65. www.globalresearchonline.net
   Google Scholar
• Sharma, C.; Khoja, R.; Vaghela, D. B. EFFECT OF AYURVEDIC TREATMENT ON DRY EYE SYNDROME (SHUSHKAAKSHIPAKA): A REVIEW. World J Pharm. Res. 2019, 8(6), 1501–1507.
   Google Scholar
• Sri Taranatha Tarkavachaspati. Vachaspatyam (A Comprehensive Sanskrit Dictionary), Vol. 6 The Chowkhamba Sanskrit Series Office: Varanasi, 1962; https://archive.org/details/vacaspatyam06tarkuoft/page/n5/mode/2up?view=theater
   Google Scholar
• Vidya, N. V.; Bineesh, E. P.; Vaghela, D. B. Pharmaceutico Analytical Study of Shunthyadi Aschyotana – An Ayurvedic Eye Drops for Shushkakshipaka (Dry Eye). World J Pharm. Res. 2020, 9(6), 2316–2325.
   Google Scholar
• Vardhan, P.; Dhiman, K. Clinical Study to Assess the Efficacy of Keshanjana and Netra Parisheka in the Management of Shushkakshipaka (Dry Eye Syndrome). AYU (An Int. Quarterly J. Res. Ayurveda). 2014, 35(3), 277. DOI: 10.4103/0974-8520.153744.
   PubMedGoogle Scholar
• Sarma, P. K. The Dhatupatha of Panini, The Chowkhamba Sanskrit Series Office: Varanasi, 1969; https://archive.org/details/DhatupathaOfPanini/Dhatupatha/page/n1/mode/2up
   Google Scholar
• Gupta, M.; Pujar, R.; Gopikrishna, S. Understanding of thirst mechanism in ayurveda. World J. Pharm. Pharm. Sci. 2020;9, 2, 1238–1247. https://www.researchgate.net/profile/Monika-Gupta-27/publication/338980594_UNDERSTANDING_OF_THIRST_MECHANISM_IN_AYURVEDA/links/5e35e8bb92851c7f7f147df6/UNDERSTANDING-OF-THIRST-MECHANISM-IN-AYURVEDA.pdf
   Google Scholar
• Mamidi, P.; Gupta, K. Sjögren’s Syndrome-Trishna Predominant Amavata? A Case Report. Int.J. Complement Altern. Med. 2019, 12(5), 174–177. DOI: 10.15406/ijcam.2019.12.00469.
   Google Scholar